344 results on '"Bar-Ad, Voichita"'
Search Results
2. A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
3. Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
4. Variance in 3D anatomic localization of surgical margins based on conventional margin labeling in head and neck squamous cell carcinoma
5. Feasibility of collagen matrix tiles with cesium-131 brachytherapy for use in the treatment of head and neck cancer
6. PREVLAR: Phase 2a randomized trial to assess the safety and efficacy of RRx-001 in the attenuation of oral mucositis in patients receiving head and neck chemoradiotherapy
7. Functional Swallow-Related Outcomes Following Transoral Robotic Surgery for Base of Tongue Carcinoma
8. SMARCB1-Retained and SMARCB1-Deficient SNUC are Genetically Distinct: A Pilot Study Using RNA Sequencing.
9. 629-B Window of opportunity for durvalumab plus metformin trial in head & neck squamous cell carcinoma (HNSCC)
10. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma
11. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
12. A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
13. Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
14. AJCC-8ed nodal staging does not predict outcomes in surgically managed HPV-associated oropharyngeal cancer
15. Disparity in age at lung cancer diagnosis between current and former smokers
16. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
17. SMARCB1-retained and SMARCB1-deficient SNUC are genetically distinct: A pilot study using RNA sequencing
18. Remote Activity Monitoring and Electronic Patient-Reported Outcomes Collection During Radiotherapy for Head and Neck Cancer: A Pilot Study
19. Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics
20. A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer
21. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment
22. Supplementary Data from Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617
23. Data from Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617
24. Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience
25. A single activity with a practice quality improvement project for faculty and a quality improvement project for residents
26. Pancreatic cancer planning: Complex conformal vs modulated therapies
27. Evaluating the quality, clinical relevance, and resident perception of the radiation oncology in-training examination: A national survey
28. In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
29. Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer
30. Radiation Therapy-Related Toxicity: Esophagus
31. Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival
32. The impact of stool and gas volume on intrafraction prostate motion in patients undergoing radiotherapy with daily endorectal balloon
33. Uncommon Tumors of the Oral Cavity and Adjacent Structures
34. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas
35. Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR).
36. Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
37. Thermoplastic Mask-Induced Contact Dermatitis: A Case Report
38. Clinical experience transitioning from IMRT to VMAT for head and neck cancer
39. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better
40. Assessing the Value of an Optional Radiation Oncology Clinical Rotation During the Core Clerkships in Medical School
41. Comparative Toxicity and Dosimetric Profile of Whole-Pelvis Versus Prostate Bed-Only Intensity-Modulated Radiation Therapy After Prostatectomy
42. Larynx-sparing techniques using intensity-modulated radiation therapy for oropharyngeal cancer
43. SPARE trial: scalp sparing radiation with concurrent temozolomide and Tumor Treating Fields (200 kHz) for patients with newly diagnosed glioblastoma
44. Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma may increase the rate of distant recurrence
45. Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
46. CTNI-19. CONCURRENT CHEMORADIATION AND TUMOR TREATING FIELDS (TTFields, 200 kHz) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MAY INCREASE THE RATE OF DISTANT RECURRENCE
47. RADT-13. SPARE TRIAL: SCALP-SPARING RADIATION WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
48. RADT-22. CONCURRENT TTFIELDS (200 KHZ) WITH CHEMORADIATION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MAY INCREASE THE RATE OF PSEUDOPROGRESSION: ANALYSIS OF A PILOT CLINICAL TRIAL
49. Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
50. Time Course of Mild Arm Lymphedema After Breast Conservation Treatment for Early-Stage Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.